Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | JSLL Jeena Sikho Lifecare Limited Pharma · Micro | QMSMEDI QMS Medical Allied Services Ltd. Pharma · SME | NEPHROCARE Nephro Care India Ltd. Pharma · SME | MAITREYA Maitreya Medicare Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 66 | 35 | 17 | 16 |
| Verdict | UNDERVALUED | WATCHLIST | OVERVALUED | OVERVALUED |
| Style | Premium Compounder | WATCHLIST | OVERVALUED | OVERVALUED |
| Piotroski | 8/9 | 8/9 | 6/9 | 6/9 |
| Valuation | 4/30 | 16/30 | 5/30 | 4/30 |
| Growth | 23/25 | 14/25 | 1/25 | 7/25 |
| Quality | 20/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 7/15 | 13/15 | 7/15 |
| Cash Flow | 4/10 | 1/10 | 2/10 | 2/10 |
| Price | ₹609 | ₹93.35 | ₹74.05 | ₹154 |
| P/E | 34.50 | 17.40 | 36.20 | — |
| P/B | 16.33 | 1.69 | 2.14 | 3.67 |
| ROE | 61.30% | 10.40% | 5.93% | -8.86% |
| ROCE | 64.10% | 13.20% | — | -2.18% |
| Debt / Equity | 0.27 | 0.65 | 0.00 | 0.80 |
| FCF Yield | 0.68% | — | 1.46% | — |
| Dividend Y | 0.18% | 0.55% | — | — |
| Altman Z | 10.01 | 2.92 | 7.27 | 2.77 |
| Promoter % | 63.62% | 68.11% | 61.71% | 73.11% |
| Mkt Cap (₹Cr) | 7644.00 | 176.00 | 122.00 | 107.00 |
| Graham # | ₹122.89 | ₹79.72 | ₹39.79 | — |
| Fair PE | 42.0 | 42.0 | 7.9 | 30.3 |
| MoS % | +18.8% | +57.6% | -357.2% | — |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startJSLL91
QMSMEDI63
NEPHROCARE41
MAITREYA118